IN FOCUS6-8 min read

Demographics: the impact of ageing populations on healthcare spending

Statistical analysis of population trends suggest a large growth opportunity for healthcare providers as a result of changing demographics.



Francesca Guinane
Investment Insights Unit Relationship Manager
Ryan Croft
Investment Insights Unit

Changing demographics globally will have a huge affect on economic growth and inflation.

There is a major focus on the shrinking pool of younger workers and the wage pressure that employers face as a result.

A larger proportion of elderly people also creates pressure on government spending, not only through pension provision, but also through the need for increased spending on healthcare.

Private companies have an opportunity to help both governments and individuals meet the challenges associated with ageing populations. Healthcare provision, whether through increased demand for services and procedures, or due to lack of healthcare professionals, is already under pressure in many major high-income countries.

Over the coming decades, ageing populations will also become prevalent in many of the middle income countries within the Organisation for Economic Co-operation and Development (OECD).

Statistical forecasting of age-related diseases

Given these trends, we have analysed where healthcare demand could be greatest both for individual countries and for various conditions. Using statistical techniques, we can forecast what future demand for age-related disease treatment and procedures could be.

We have forecasted prevalence for age-related diseases using a time series forecasting method called "exponential smoothing". Taking current and historic estimates from The Institute for Health Metrics and Evaluation (IHME), we can map this data to the current population and future population forecasts.

Exponential smoothing uses historic trends, placing more weight on the recent past, in order to forecast future trends with constraints in place to prevent unrealistic estimates.

Our analysis shows that age-related diseases such as osteoarthritis, kidney disease, high blood pressure, dementia, and obstructive pulmonary disease are likely to grow faster than non-age-related diseases because of an ageing population.

It is worth noting that often multiple age-related diseases are experienced by an individual at any point in time. Japan is the only example from our analysis that will experience a smaller amount of change due to the country’s existing age profile.


Nearly every high income country will experience ageing populations until approximately 2050, although the rate of ageing will vary widely. We see a rapid acceleration of the over 70s population and fast decline back to lower levels in South Korea, Italy and Spain. Meanwhile, the UK, US, Canada and Australia should see a more gradual increase in the number of over 70s, but also a slower decline in the following decades.


If we focus on the US as an example, using healthcare spending by age-related disease, we can see the difference demographic and disease prevalence forecasts will have on spending (keeping the cost per disease the same as today). Across a range of different diseases and conditions, we have forecasted a large and necessary increase in spend driven purely by volumes. Of the age-related diseases, cardiovascular and musculoskeletal will continue to be the largest spend.


As well as age-related diseases, the need for hip and knee replacement procedures is likely to rise as populations age.

Large growth opportunity for healthcare providers

These projections could be considered when planning for future healthcare needs, resource allocation and investment opportunities within the healthcare sector.

On average in the OECD, hip replacement rates increased by 22% between 2009 and 2019 and knee replacement rates by 35%. This aligns with the rising incidence and prevalence of osteoarthritis, caused by ageing populations and growing obesity rates.


Using the same methodology, our forecasts suggest knee and hip replacements volumes could increase by 100% in Australia 70% in Canada and 50% in Italy and UK by 2050.

Taking all of these forecasts into consideration, there is a large opportunity for expansion for healthcare providers and medical equipment providers in these countries.

Important information: The views and opinions contained herein are those of the author(s) on this page, and may not necessarily represent views expressed or reflected in other Schroders communications, strategies or funds. This article is intended to be for information purposes only and it is not intended as promotional material in any respect. The material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The material is not intended to provide, and should not be relied on for, accounting, legal or tax advice, or investment recommendations. Information herein is believed to be reliable but Schroders does not warrant its completeness or accuracy. No responsibility can be accepted for errors of fact or opinion. Reliance should not be placed on the views and information in the document when taking individual investment and/or strategic decisions. Past performance is not a reliable indicator of future results, prices of shares and the income from them may fall as well as rise and investors may not get back the amount originally invested. Issued by Schroder Investment Management Limited, 31 Gresham Street, London EC2V 7QA, which is authorised and regulated by the Financial Conduct Authority. For your security, communications may be taped or monitored.


Francesca Guinane
Investment Insights Unit Relationship Manager
Ryan Croft
Investment Insights Unit


Follow us

Schroder International Selection Fund is referred to as Schroder ISF throughout this website.

For illustrative purposes only and does not constitute a recommendation to invest in the above-mentioned security / sector / country.

Schroder Investment Management (Europe) S.A. is subject to the UCITS law of 17 December 2010 and the AIFM law of 12 July 2013.